RNAV8 Bio
Pre-clinicalRNAV8’s (pronounced “renovate”) toolkit for engineering mRNA provides an unfair advantage in expression tuning and maximization via non-coding sequence optimization
Founded
2021
Focus
RNA TherapeuticsInfectious DiseaseVaccines
About
RNAV8’s (pronounced “renovate”) toolkit for engineering mRNA provides an unfair advantage in expression tuning and maximization via non-coding sequence optimization
Funding History
1Total raised: $12M
Seed$12MMubadala CapitalMar 15, 2023
Company Info
TypePrivate
Founded2021
LocationCambridge, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile